(Q37977361)

26 August 2017

title

Serum levels of matrix metalloproteinases: implications in clinical neurology (English)

1 reference

26 August 2017

3

Nils Erik Gilhus

1 reference

26 August 2017

Fredrik Romi

1

1 reference

26 August 2017

Geir Helgeland

series ordinal

2

1 reference

26 August 2017

publication date

19 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

67

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

121-128

1 reference

Targeting MMPs in acute and chronic neurological conditions

26 August 2017

cites work

1 reference

Matrix metalloproteinase proteomics: substrates, targets, and therapy.

21 January 2018

1 reference

Progress in matrix metalloproteinase research

21 January 2018

1 reference

Insights into MMP-TIMP interactions.

21 January 2018

1 reference

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction

21 January 2018

1 reference

Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4

21 January 2018

1 reference

Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study

21 January 2018

1 reference

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

21 January 2018

1 reference

Development of the neuromuscular junction

21 January 2018

1 reference

MMP-1 polymorphism and its relationship to pathological processes.

21 January 2018

1 reference

Autoantibody and biopsy grading are associated with expression of ICAM-1, MMP-3, and TRAIL in salivary gland mononuclear cells of Chinese patients with Sjogren's syndrome.

21 January 2018

1 reference

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

21 January 2018

1 reference

Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker

21 January 2018

1 reference

Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation

21 January 2018

1 reference

21 January 2018

1 reference

The causal cascade to multiple sclerosis: a model for MS pathogenesis

21 January 2018

1 reference

Environmental factors and multiple sclerosis.

21 January 2018

1 reference

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b

21 January 2018

1 reference

Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice

21 January 2018

1 reference

Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.

21 January 2018

1 reference

Intravenous immunoglobulin therapy prevents development of autoimmune encephalomyelitis and suppresses activation of matrix metalloproteinases.

21 January 2018

1 reference

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

21 January 2018

1 reference

PEG minocycline-liposomes ameliorate CNS autoimmune disease

21 January 2018

1 reference

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

Therapeutic options in ocular myasthenia gravis

21 January 2018

1 reference

Ocular myasthenia: diagnostic and treatment recommendations and the evidence base

21 January 2018

1 reference

Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis

21 January 2018

1 reference

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

21 January 2018

1 reference

Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle.

21 January 2018

1 reference

Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering

21 January 2018

1 reference

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance

21 January 2018

1 reference

An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope

21 January 2018

1 reference

Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis

21 January 2018

1 reference

Matrix metalloproteinases in myasthenia gravis.

21 January 2018

1 reference

Regulation of matrix metalloproteinases: an overview

21 January 2018

1 reference

A biochemical model of matrix metalloproteinase 9 activation and inhibition

21 January 2018

1 reference

Activation of Matrix Metalloproteinase-3 is altered at the frog neuromuscular junction following changes in synaptic activity

21 January 2018

1 reference

Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice

21 January 2018

1 reference

Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review

21 January 2018

1 reference

A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke

21 January 2018

1 reference

Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan

21 January 2018

1 reference

Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.

21 January 2018

1 reference

Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion

21 January 2018

1 reference

Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke

21 January 2018

1 reference

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

21 January 2018

1 reference

Important role of matrix metalloproteinase 9 in epileptogenesis

21 January 2018

1 reference

Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity.

21 January 2018

1 reference

Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000334862

1 reference

26 August 2017

1 reference